Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamatha Bhat

Showing results (21-30 of 210) with videos related to

Pageof 21
Sort By:
Gastroenterology|November 18, 2022
OrganEx: A Promising Solution for Rescuing Organs After Prolonged IschemiaAnh Thu Nguyen-Lefebvre, Mamatha Bhat
Journal of Hepatology|March 29, 2017
Reply to: "Proposal of a novel MELD exception point system for hepatocellular carcinoma: Dynamics better than tumor characteristics?"Mamatha Bhat, Peter Ghali, Marc Bilodeau
Pharmaceutics|January 21, 2022
Nanomedicine in Hepatocellular Carcinoma: A New Frontier in Targeted Cancer TreatmentAnita Bakrania, Gang Zheng, Mamatha Bhat
Gastroenterology|May 19, 2024
Hotspot Immune Exhaustion: Key to Liver Transplant RejectionAnh Thu Nguyen-Lefebvre, Mamatha Bhat
World Journal of Hepatology|July 4, 2015
Systematic review: Preventive and therapeutic applications of metformin in liver diseaseAparna Bhat, Giada Sebastiani, Mamatha Bhat
Plos One|September 28, 2017
Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: A meta-analysisMamatha Bhat, Mahmood Tazari, Giada Sebastiani
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 19, 2022
Deep learning and the future of the Model for End-Stage Liver Disease-sodium scoreMichael Cooper, Rahul G Krishnan, Mamatha Bhat
Hepatology (Baltimore, Md.)|February 15, 2013
The mTOR pathway in hepatic malignanciesMamatha Bhat, Nahum Sonenberg, Gregory J Gores
Experimental Gerontology|March 29, 2026
Corrigendum to "Mammalian target of rapamycin in chronic liver disease and the potential for therapeutic manipulation" [Exp. Gerontol. Volume 217 (May 2026) 113105]Pramudi Wijayasiri, Mamatha Bhat, Aloysious D Aravinthan
Experimental Gerontology|March 21, 2026
Mammalian target of rapamycin in chronic liver disease and the potential for therapeutic manipulationPramudi Wijayasiri, Mamatha Bhat, Aloysious D Aravinthan
Pageof 21

Showing results (21-30 of 210) with videos related to

Sort By:
Pageof 21
Gastroenterology|November 18, 2022
OrganEx: A Promising Solution for Rescuing Organs After Prolonged IschemiaAnh Thu Nguyen-Lefebvre, Mamatha Bhat
Journal of Hepatology|March 29, 2017
Reply to: "Proposal of a novel MELD exception point system for hepatocellular carcinoma: Dynamics better than tumor characteristics?"Mamatha Bhat, Peter Ghali, Marc Bilodeau
Pharmaceutics|January 21, 2022
Nanomedicine in Hepatocellular Carcinoma: A New Frontier in Targeted Cancer TreatmentAnita Bakrania, Gang Zheng, Mamatha Bhat
Gastroenterology|May 19, 2024
Hotspot Immune Exhaustion: Key to Liver Transplant RejectionAnh Thu Nguyen-Lefebvre, Mamatha Bhat
World Journal of Hepatology|July 4, 2015
Systematic review: Preventive and therapeutic applications of metformin in liver diseaseAparna Bhat, Giada Sebastiani, Mamatha Bhat
Plos One|September 28, 2017
Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: A meta-analysisMamatha Bhat, Mahmood Tazari, Giada Sebastiani
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 19, 2022
Deep learning and the future of the Model for End-Stage Liver Disease-sodium scoreMichael Cooper, Rahul G Krishnan, Mamatha Bhat
Hepatology (Baltimore, Md.)|February 15, 2013
The mTOR pathway in hepatic malignanciesMamatha Bhat, Nahum Sonenberg, Gregory J Gores
Experimental Gerontology|March 29, 2026
Corrigendum to "Mammalian target of rapamycin in chronic liver disease and the potential for therapeutic manipulation" [Exp. Gerontol. Volume 217 (May 2026) 113105]Pramudi Wijayasiri, Mamatha Bhat, Aloysious D Aravinthan
Experimental Gerontology|March 21, 2026
Mammalian target of rapamycin in chronic liver disease and the potential for therapeutic manipulationPramudi Wijayasiri, Mamatha Bhat, Aloysious D Aravinthan
Pageof 21